CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for PreMD Inc.(USA) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

PreMD Inc.(USA)
4211 Yonge Street, Suite 242
Phone: (416) 222-3449p:416 222-3449 TORONTO, ON  M2P 2A9  Canada Ticker: PREMFPREMF

Business Summary
PreMD Inc is a Canada-based medical device company. The Company is engaged in the development and sale of non-invasive tests that detect early stage cardiovascular diseases and cancers. The Company’s products include PREVU Skin Sterol Test, ColorectAlert, LungAlert and Breast Cancer Test. The Company's PREVU Skin Sterol Test is a simple, non-invasive skin cholesterol test that is used in the determination of the risk assessment of coronary artery disease (CAD). The Company’s ColorectAlert is a screening test for colorectal cancer. LungAler is a screening test for colorectal cancer. Breast Cancer Test is a screening test for breast cancer. In addition to this, the Company has a number of products in its pipeline, which are in various stages of development. The products include the Color Measurement product, Other Cancers product, Colopath and the Genomics products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200812/31/2007YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8071 Medical laboratories

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Stephen A.Wilgar 70 3/17/1993
President, Chief Executive Officer, Director H. B. BrentNorton 47 3/17/1993 1/1/1992
Chief Financial Officer CatherineAuld 11/14/2008 11/14/2008
3 additional Officers and Directors records available in full report.

Business Names
Business Name
IMI International Medical Innov. (USA)
IMI International Medical Innovations
IMI INTERNATIONAL MEDICAL INNOVATIONS INC
5 additional Business Names available in full report.

General Information
Number of Employees: 18 (As of 4/15/2006)
Outstanding Shares: 30,722,638 (As of 12/31/2008)
Shareholders: 335
Stock Exchange: OTC
Fax Number: (416) 222-3449


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023